With the development of the economy and healthcare, percutaneous coronary intervention (PCI) has rapidly grown in various types of coronary heart disease treatment due to its minimally invasive, time-saving, safe, and effective advantages. As one of the most commonly used interventional procedures for cardiovascular diseases, PCI exists in multiple forms, including percutaneous coronary angioplasty, coronary artery stenting, and drug-eluting balloons. More advanced drug-coated balloons have also received widespread attention and clinical use in recent years. With the upgrading of clinical needs, continuous technological progress, and the continuous penetration of the concept of 'no implantation during intervention', percutaneous coronary intervention consumables will continue to develop, with broad market prospects ahead. For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released an independent market research report titled 'Independent Market Study on Percutaneous Coronary Intervention Consumables'.
If you have further research needs on the independent market for percutaneous coronary intervention consumables, please contact us at any time:
Mr. Mao from Frost & Sullivan
Tel: (+86) 159 2139 6033
E-mail: fred.mao@frostchina.com
